Structured Capital

Structured Capital

Row of test tubes with liquid, pink background
3D image to illustrate the partnership approach taken by Structured Capital investment teams at ICG
Seeking solutions in the maze-shaped human brain, 3D - Computer generated image
Scroll Down

Structured Capital

Provides structured capital solutions to private companies, including both control transactions and minority investments.

Broadly these are for high quality mid-market and upper mid-market private companies with enterprise values of €100m to €2bn.

Regions

  • Asia-Pacific
  • North America
  • Western Europe

$7.5bn of fundraising for Structured Capital strategies in the 12 months to 31 March 2025.

Structured Capital at a glance

$28.6bn

Total assets under management (AUM)

(31 March 2025)

25%

Of Total AUM

(31 March 2025)

7-12 years

Indicative length of fund contractual life1

1. Representative for Structured Capital, Private Equity Secondaries and Private Debt as a whole, there will be variation within the asset classes. Length is at inception, excluding potential for extensions.

Structured Capital strategies

  • 01
  • 02
  • 03
  • 04
01

European Corporate

European Corporate

Flagship strategy with a 36-year track record, targeting locally sourced, directly originated and privately negotiated investments in European corporates

Seeks consistent, high returns through the cycles

Explore European Corporate
02

European Mid-Market

European Mid-Market

Strategy focused purely on mid-sized companies

Seeks consistent, high returns through the cycles

Explore European Mid-Market
03

Asia Pacific Corporate

Asia Pacific Corporate

Wooseok Jun

Head of Asia-Pacific Corporate

Structured Capital

Hong Kong

Targets locally sourced flexible subordinated debt and equity investments in Asia Pacific middle market companies

Strategy pursues private equity-like returns with reduced volatility

Explore Asia Pacific Corporate
04

Life Sciences

Life Sciences

Toby Sykes

Managing Director, Life Sciences

Structured Capital

London

Focused on creating and building life science companies addressing commercially attractive markets

Aims to build a portfolio of preclinical and clinical stage growth opportunities

Explore Life Sciences
The ICG Client Lounge visible on a laptop

Explore the ICG Client Lounge

For clients and their consultants to explore the entire ICG global investment platform.

Request Access

Get in touch

To find out more about our flexible and sustainable solutions for both providers and users of capital, please contact us.

Contact us
3D image to illustrate the partnership approach taken by Structured Capital investment teams at ICG